Bioinformatics Tools for Screening of Antiparasitic Drugs

被引:7
|
作者
de Azevedo, Walter Filgueira, Jr. [1 ]
Dias, Raquel [1 ]
Saraiva Macedo Timmers, Luis Fernando [1 ]
Pauli, Ivani [1 ]
Caceres, Rafael Andrade [1 ,2 ]
Pereira Soares, Milena Botelho [3 ,4 ]
机构
[1] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Lab Bioquim Estrutural, Porto Alegre, RS, Brazil
[2] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Med & Ciencias Saude, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil
[3] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil
[4] Hosp Sao Rafael, BR-41253190 Salvador, BA, Brazil
关键词
Virtual screening; protein-ligand; docking; empirical scoring function; protein target; drug development; in silico screening; PURINE NUCLEOSIDE PHOSPHORYLASE; EMPIRICAL SCORING FUNCTIONS; PROTEIN DATA-BANK; INCREMENTAL CONSTRUCTION ALGORITHM; LIGAND-BINDING AFFINITY; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR DOCKING; CRYSTAL-STRUCTURE; AUTOMATED DOCKING; HUMAN PNP;
D O I
10.2174/138945009787581122
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug development has become the Holy Grail of many structural bionformatics groups. The explosion of information about protein structures, ligand-binding affinity, parasite genome projects, and biological activity of millions of molecules opened the possibility to correlate this scattered information in order to generate reliable computational models to predict the likelihood of being able to modulate a target with a small-molecule drug. Computational methods have shown their potential in drug discovery and development allied with in vitro and in vivo methodologies. The present review discusses the main bioinformatics tools available for drug discovery and development.
引用
收藏
页码:232 / 239
页数:8
相关论文
共 50 条
  • [41] Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer
    Dan Yang
    Yang He
    Bo Wu
    Yan Deng
    Nan Wang
    Menglin Li
    Yang Liu
    Journal of Ovarian Research, 13
  • [42] Screening of potential hub genes and key pathways associated with breast cancer by bioinformatics tools
    Oumeddour, Abdelkader
    MEDICINE, 2023, 102 (11) : E33291
  • [43] Key current antiparasitic drugs – uses and limitations
    H. Mehlhorn
    O. Kayser
    Parasitology Research, 2003, 90 : S1 - S2
  • [44] Progress in Redirecting Antiparasitic Drugs for Cancer Treatment
    Huang, Haoyang
    He, Qing
    Guo, Binghua
    Xu, Xudong
    Wu, Yinjuan
    Li, Xuerong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2747 - 2767
  • [45] Resistance to antiparasitic drugs: the role of molecular diagnosis
    Sangster, N
    Batterham, P
    Chapman, HD
    Duraisingh, M
    Le Jambre, L
    Shirley, M
    Upcroft, J
    Upcroft, P
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2002, 32 (05) : 637 - 653
  • [46] EMBRYOTOXICITY OF ANTIPARASITIC DRUGS IN SHEEP - CLINICAL OBSERVATION
    FABRE, JM
    BERTHELOT, X
    FERNEY, J
    REVUE DE MEDECINE VETERINAIRE, 1989, 140 (12) : 1089 - 1095
  • [48] INTERACTION OF HOST PHYSIOLOGY AND EFFICACY OF ANTIPARASITIC DRUGS
    PRICHARD, RK
    VETERINARY PARASITOLOGY, 1985, 18 (02) : 103 - 110
  • [49] CHITIN METABOLISM - A TARGET FOR ANTIFUNGAL AND ANTIPARASITIC DRUGS
    GOODAY, GW
    PHARMACOLOGY & THERAPEUTICS, 1990, : 175 - 185
  • [50] Antihelminthic and antiparasitic drugs: Unapproved used or indications
    Goihman-Yahr, M
    CLINICS IN DERMATOLOGY, 2000, 18 (01) : 113 - 117